Clinical Trials Directory

Trials / Completed

CompletedNCT02597985

Prehabilitation to Improve Functional and Clinical Outcomes in Patients With Aortic Stenosis

Prehabilitation to Improve Functional and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement: TAVR-FRAILTY Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

Transcatheter aortic valve replacement (TAVR) is a treatment alternative among high-risk elderly with aortic stenosis, however, mortality remains high. Fifty percent of patients undergoing TAVR exhibit frailty, a syndrome associated with poor survival. It is unknown whether interventions to improve frailty before TAVR (prehabilitation) will improve outcomes after TAVR. This study plans to evaluate whether simple cardiac exercise interventions to improve physical performance before TAVR improves outcomes after TAVR.

Conditions

Interventions

TypeNameDescription
OTHERPrehabilitationSupervised exercise training intervention will include three sessions per week for four weeks at a Mayo Clinic system cardiac rehabilitation facility. The Rochester, Minnesota Cardiac Rehabilitation Program will provide guidance and oversight. Modes of aerobic exercise will include treadmill walking (the primary mode of training) supplemented with non-weight-bearing activities such as stationary cycling and combination arm/leg recumbent exercise (NuStep device), as needed. Intensity will be set using Borg Perceived Exertion Scale (RPE) ratings of 12-14 (somewhat hard), keeping patients below the threshold for more than mild angina.
OTHERUsual Care

Timeline

Start date
2015-10-01
Primary completion
2019-06-17
Completion
2019-09-10
First posted
2015-11-05
Last updated
2021-12-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02597985. Inclusion in this directory is not an endorsement.